Can Chronic Pain Lead to Suicide?
People dealing with chronic pain have a greater risk of dying by suicide than the general population. About 5% to 14% of chronic pain patients attempt suicide, while about 32% report suicide ideation. Several factors influence the risk of suicidality among chronic pain patients, including those related to the pain itself, sleep, psychological effects, and mental […]
ZICOH® Technology by Vivera Granted Second U.S. Patent (US 11,090,449) for Smart Inhaler Device
NEWPORT BEACH, Calif. – The U.S. Patent and Trademark Office (USPTO) has granted Vivera’s ZICOH® technology a second U.S. Patent, No. 11,090,449. Vivera is pleased to announce ZICOH’s second patent grant as it secures ZICOH’s rights as a smart inhaler device featuring automated dose delivery, measurement, and management of medications. This news comes just one week […]
Vivera Pharmaceuticals Receives U.S. Patent (US 11,083,850) for ZICOH®
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc. (Vivera) today announced that the U.S. Patent and Trademark Office (USPTO) issued U.S. Patent No. 11,083,850 for ZICOH®, the Company’s wireless, electronic, dose-controlled medication delivery device. ZICOH, a secure, smart dosing device, was designed as part of a closed-loop medication management system backed by software and technology. Broadly […]
5 Ways the COVID-19 Pandemic Worsened the Opioid Crisis
The number of people dying from a drug overdose has been steadily increasing every year since the 1990s. Although there was a slight decline in 2018, overdose deaths picked up in 2019. When the COVID-19 pandemic started in 2020, overdose deaths spiked significantly. According to preliminary data released from the Centers for Disease Control and […]
Can Mindfulness Meditation Help with Chronic Pain?
Pain affects millions of adults in the United States every year. Many times, pain is acute, lasting until an injury or surgical wound heals. Other times, it can be chronic, persisting for at least three months. The latter can be frustrating, especially when the cause is not obvious. Unfortunately, many medications that are used to […]
Arthritis Pain: Causes and Treatments
Chronic pain affects more than 20 percent of adults in the United States. Many people attribute their pain to arthritis, which is the inflammation of one or more joints. According to the Centers for Disease Control and Prevention (CDC), 54 million people in the U.S. have arthritis. About a quarter of those with arthritis experience severe pain, and […]
Vivera Pharmaceuticals Responds to New Safety Protocols with Expanded Access to COVID-19 Testing, Vaccines, and Personal Protective Equipment
NEWPORT BEACH, Calif. – In response to new nationwide mask and testing mandates, Vivera Pharmaceuticals has expanded access to testing resources, vaccine clinics, and personal protective equipment (PPE). With an increase in the number of COVID-19 cases across the country, a resurgence of hospitalizations is being attributed to more transmissible mutations of the virus, like […]
What is a Fluency Disorder?
Most people experience disfluencies while speaking from time to time. However, if disfluencies are the norm, then the cause may be a fluency disorder. A fluency disorder is an interruption in the flow of speaking, characterized by atypical rate, rhythm, and disfluencies. The two main types of fluency disorders are stuttering and cluttering. Fluency disorders […]
Medications Used to Treat Opioid Use Disorder
There is a common misconception that those who use prescription medications to treat opioid use disorder (OUD) are trading one addiction for the other. While two of the drugs used to treat OUD are opioids, these drugs are not just substitutes for other opioids; they can be life-saving for those suffering from the disease. Here’s […]
Q2 2021 Newsletter
Table of Contents Add a header to begin generating the table of contents INVESTOR/AUDIT UPDATE Despite global delays during the COVID-19 pandemic, Vivera engaged international audit firm, Mazars USA LLP, to complete our public audit for fiscal years 2019 and 2020. We are very close to finalizing the 2019 audit and are starting the 2020 […]
